More Research Backs Migraine Meds as Heart Safe

🔗 Access full article via Medscape Neurology

Anti-CGRP antibodies vs onabotulinumtoxinA is not associated with increased cardiovascular disease risk in older patients with migraine, new research suggested.
Medscape Medical News